Based on the SMILES representation CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23, the molecule has a drug half life time in humans after IV administration of 8.900 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid